Position
Bridgewater in Vaxcyte, Inc.
Back to the book · All holders of PCVX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $258$58.11 → $58.13
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q1 2026 | 12.9K | $749.8K | — | — | — | 0.0% |
| Q2 2026 | 50.2K | $2.92M | $58.13 | $258 | $2.17M | 0.0% |